The Motley Fool

With its 11% dividend yield, is the WAM Research share price a buy?

Is the WAM Research Limited (ASX: WAX) share price a buy for the grossed-up dividend yield of 11%?

WAM Research is a listed investment company (LIC) operated by Wilson Asset Management.

It’s the highest dividend yield that WAM Research has traded at for some time, largely because the premium to the underlying net tangible assets (NTA) has significantly narrowed in recent months.

Using the March 2019 pre-tax NTA of $1.16, the current share price of $1.25 means it’s now trading at a premium of ‘only’ 7.8%. For much of the past year or two it has been trading with a premium of more than 20%, sometimes around 25%.

There are two probable causes of the premium closing up. The first is investor worry surrounding the potential change to franking credits, which would reduce the attractiveness of high-yield dividend shares like WAM Research.

The other is that WAM Research’s investment portfolio performance has been pretty disappointing over the past year, underperforming the S&P/ASX All Ordinaries Accumulation Index by 11.7%.

However, the dividend potential of WAM Research still remains. It still has a sizeable profit reserve to continue to pay dividends unless there’s a large market crash. It continues to hold a good amount of cash for protection and opportunities, being 23.9% of the portfolio at 31 March 2019. It continues to target a growing dividend for shareholders.

Performance can swing year to year, so although it has underperformed the market over the past 12 months, the next 12 months could be much better. WAM Research’s investment performance still shows it has outperformed its benchmark by an average of 6.7% per annum before fees and expenses over the past seven years.

Foolish takeaway

WAM Research’s current annualised dividend yield is very attractive for income investors. Even if Labor win, they may not have the votes in the senate to change the franking credit rules. I’d consider investing in WAM Research shares today for income in my portfolio.

Here are three other great ASX income shares to consider for dividends.


The Motley Fool Australia just hand-picked 3 top dividend shares for 2019... and for a brief time, you’re invited to access this valuable research for FREE.

To discover our favourite 3 dividend buys to potentially profit in the next 12 months, simply click here or the link below right now. You’ll receive all 3 names... codes... and every detail you need to decide to invest in these shares today.

If you’re looking for that magical combination of growth potential and fully franked dividends, then look no further. But if you wait, you could miss out! This report is available for a limited time only, so please, don’t delay. Click the link below to scoop up your access now.


Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more